nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A3—Irinotecan—pancreatic cancer	0.215	0.338	CbGbCtD
Dopamine—CYP1A2—Dacarbazine—pancreatic cancer	0.0634	0.0996	CbGbCtD
Dopamine—CYP2C19—Tamoxifen—pancreatic cancer	0.0547	0.0858	CbGbCtD
Dopamine—CYP1A2—Tamoxifen—pancreatic cancer	0.0505	0.0792	CbGbCtD
Dopamine—CYP2C9—Tamoxifen—pancreatic cancer	0.0455	0.0714	CbGbCtD
Dopamine—CYP1A2—Erlotinib—pancreatic cancer	0.0429	0.0673	CbGbCtD
Dopamine—CYP2D6—Tamoxifen—pancreatic cancer	0.0416	0.0653	CbGbCtD
Dopamine—CYP1A2—Fluorouracil—pancreatic cancer	0.0372	0.0584	CbGbCtD
Dopamine—CYP2D6—Erlotinib—pancreatic cancer	0.0354	0.0555	CbGbCtD
Dopamine—CYP2C9—Fluorouracil—pancreatic cancer	0.0335	0.0526	CbGbCtD
Dopamine—CYP2D6—Doxorubicin—pancreatic cancer	0.0174	0.0274	CbGbCtD
Dopamine—Piloerection—Irinotecan—pancreatic cancer	0.0118	0.149	CcSEcCtD
Dopamine—Gangrene—Gemcitabine—pancreatic cancer	0.00912	0.116	CcSEcCtD
Dopamine—HTR7—enteric nervous system—pancreatic cancer	0.00264	0.454	CbGeAlD
Dopamine—Necrosis—Fluorouracil—pancreatic cancer	0.00249	0.0316	CcSEcCtD
Dopamine—Extravasation—Irinotecan—pancreatic cancer	0.00234	0.0297	CcSEcCtD
Dopamine—Extravasation—Gemcitabine—pancreatic cancer	0.00228	0.0289	CcSEcCtD
Dopamine—Extravasation—Fluorouracil—pancreatic cancer	0.00224	0.0284	CcSEcCtD
Dopamine—Mesalazine—PPARG—pancreatic cancer	0.00193	0.517	CrCbGaD
Dopamine—Necrosis—Docetaxel—pancreatic cancer	0.0018	0.0228	CcSEcCtD
Dopamine—Angina pectoris—Tamoxifen—pancreatic cancer	0.00177	0.0224	CcSEcCtD
Dopamine—Extravasation—Docetaxel—pancreatic cancer	0.00162	0.0205	CcSEcCtD
Dopamine—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.00129	0.0163	CcSEcCtD
Dopamine—Bradycardia—Sunitinib—pancreatic cancer	0.00127	0.0161	CcSEcCtD
Dopamine—Angina pectoris—Irinotecan—pancreatic cancer	0.00125	0.0158	CcSEcCtD
Dopamine—Necrosis—Epirubicin—pancreatic cancer	0.00121	0.0154	CcSEcCtD
Dopamine—Angina pectoris—Fluorouracil—pancreatic cancer	0.0012	0.0152	CcSEcCtD
Dopamine—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.00119	0.0151	CcSEcCtD
Dopamine—Necrosis—Doxorubicin—pancreatic cancer	0.00112	0.0142	CcSEcCtD
Dopamine—Hypertension—Tamoxifen—pancreatic cancer	0.00109	0.0139	CcSEcCtD
Dopamine—Extravasation—Epirubicin—pancreatic cancer	0.00109	0.0138	CcSEcCtD
Dopamine—Atrial fibrillation—Docetaxel—pancreatic cancer	0.00108	0.0137	CcSEcCtD
Dopamine—Anxiety—Tamoxifen—pancreatic cancer	0.00107	0.0136	CcSEcCtD
Dopamine—Anxiety—Erlotinib—pancreatic cancer	0.00106	0.0135	CcSEcCtD
Dopamine—Bradycardia—Irinotecan—pancreatic cancer	0.00105	0.0132	CcSEcCtD
Dopamine—Extravasation—Doxorubicin—pancreatic cancer	0.00101	0.0128	CcSEcCtD
Dopamine—Epinephrine—TNF—pancreatic cancer	0.000989	0.265	CrCbGaD
Dopamine—Hypertension—Sunitinib—pancreatic cancer	0.000937	0.0119	CcSEcCtD
Dopamine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000922	0.0117	CcSEcCtD
Dopamine—Dyspnoea—Erlotinib—pancreatic cancer	0.000912	0.0115	CcSEcCtD
Dopamine—Angina pectoris—Docetaxel—pancreatic cancer	0.000864	0.0109	CcSEcCtD
Dopamine—Mesalazine—PTGS2—pancreatic cancer	0.000815	0.218	CrCbGaD
Dopamine—Dyspnoea—Sunitinib—pancreatic cancer	0.000789	0.01	CcSEcCtD
Dopamine—Hypertension—Irinotecan—pancreatic cancer	0.000772	0.00977	CcSEcCtD
Dopamine—Hypertension—Gemcitabine—pancreatic cancer	0.000752	0.00952	CcSEcCtD
Dopamine—Tachycardia—Fluorouracil—pancreatic cancer	0.000682	0.00863	CcSEcCtD
Dopamine—Vomiting—Tamoxifen—pancreatic cancer	0.000657	0.00832	CcSEcCtD
Dopamine—Vomiting—Erlotinib—pancreatic cancer	0.00065	0.00824	CcSEcCtD
Dopamine—Dyspnoea—Irinotecan—pancreatic cancer	0.00065	0.00823	CcSEcCtD
Dopamine—Headache—Tamoxifen—pancreatic cancer	0.000648	0.0082	CcSEcCtD
Dopamine—Headache—Erlotinib—pancreatic cancer	0.000641	0.00811	CcSEcCtD
Dopamine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000633	0.00802	CcSEcCtD
Dopamine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000623	0.00789	CcSEcCtD
Dopamine—Nausea—Tamoxifen—pancreatic cancer	0.000614	0.00778	CcSEcCtD
Dopamine—Nausea—Erlotinib—pancreatic cancer	0.000608	0.00769	CcSEcCtD
Dopamine—Angina pectoris—Epirubicin—pancreatic cancer	0.000582	0.00738	CcSEcCtD
Dopamine—Vomiting—Sunitinib—pancreatic cancer	0.000563	0.00713	CcSEcCtD
Dopamine—Headache—Sunitinib—pancreatic cancer	0.000555	0.00702	CcSEcCtD
Dopamine—Palpitations—Docetaxel—pancreatic cancer	0.000546	0.00691	CcSEcCtD
Dopamine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000539	0.00683	CcSEcCtD
Dopamine—Hypertension—Docetaxel—pancreatic cancer	0.000533	0.00675	CcSEcCtD
Dopamine—Nausea—Sunitinib—pancreatic cancer	0.000526	0.00666	CcSEcCtD
Dopamine—Tachycardia—Docetaxel—pancreatic cancer	0.000492	0.00623	CcSEcCtD
Dopamine—Bradycardia—Epirubicin—pancreatic cancer	0.000487	0.00617	CcSEcCtD
Dopamine—Vomiting—Irinotecan—pancreatic cancer	0.000464	0.00587	CcSEcCtD
Dopamine—Headache—Irinotecan—pancreatic cancer	0.000457	0.00579	CcSEcCtD
Dopamine—Vomiting—Gemcitabine—pancreatic cancer	0.000452	0.00572	CcSEcCtD
Dopamine—Bradycardia—Doxorubicin—pancreatic cancer	0.000451	0.00571	CcSEcCtD
Dopamine—Dyspnoea—Docetaxel—pancreatic cancer	0.000449	0.00569	CcSEcCtD
Dopamine—Headache—Gemcitabine—pancreatic cancer	0.000445	0.00564	CcSEcCtD
Dopamine—Vomiting—Fluorouracil—pancreatic cancer	0.000444	0.00562	CcSEcCtD
Dopamine—Headache—Fluorouracil—pancreatic cancer	0.000438	0.00554	CcSEcCtD
Dopamine—Nausea—Irinotecan—pancreatic cancer	0.000433	0.00549	CcSEcCtD
Dopamine—Nausea—Gemcitabine—pancreatic cancer	0.000422	0.00534	CcSEcCtD
Dopamine—Nausea—Fluorouracil—pancreatic cancer	0.000415	0.00525	CcSEcCtD
Dopamine—DBH—digestive system—pancreatic cancer	0.000413	0.0709	CbGeAlD
Dopamine—Palpitations—Epirubicin—pancreatic cancer	0.000368	0.00466	CcSEcCtD
Dopamine—COMT—islet of Langerhans—pancreatic cancer	0.000364	0.0624	CbGeAlD
Dopamine—Hypertension—Epirubicin—pancreatic cancer	0.00036	0.00456	CcSEcCtD
Dopamine—Anxiety—Epirubicin—pancreatic cancer	0.000353	0.00448	CcSEcCtD
Dopamine—Palpitations—Doxorubicin—pancreatic cancer	0.000341	0.00431	CcSEcCtD
Dopamine—Hypertension—Doxorubicin—pancreatic cancer	0.000333	0.00422	CcSEcCtD
Dopamine—Tachycardia—Epirubicin—pancreatic cancer	0.000332	0.0042	CcSEcCtD
Dopamine—Anxiety—Doxorubicin—pancreatic cancer	0.000327	0.00414	CcSEcCtD
Dopamine—Vomiting—Docetaxel—pancreatic cancer	0.000321	0.00406	CcSEcCtD
Dopamine—Headache—Docetaxel—pancreatic cancer	0.000316	0.004	CcSEcCtD
Dopamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000307	0.00389	CcSEcCtD
Dopamine—Dyspnoea—Epirubicin—pancreatic cancer	0.000303	0.00384	CcSEcCtD
Dopamine—Nausea—Docetaxel—pancreatic cancer	0.000299	0.00379	CcSEcCtD
Dopamine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000281	0.00355	CcSEcCtD
Dopamine—SLC22A2—digestive system—pancreatic cancer	0.000272	0.0467	CbGeAlD
Dopamine—COMT—pancreas—pancreatic cancer	0.000256	0.0439	CbGeAlD
Dopamine—MAOA—islet of Langerhans—pancreatic cancer	0.000241	0.0414	CbGeAlD
Dopamine—COMT—digestive system—pancreatic cancer	0.000218	0.0375	CbGeAlD
Dopamine—Vomiting—Epirubicin—pancreatic cancer	0.000216	0.00274	CcSEcCtD
Dopamine—Headache—Epirubicin—pancreatic cancer	0.000213	0.0027	CcSEcCtD
Dopamine—Nausea—Epirubicin—pancreatic cancer	0.000202	0.00256	CcSEcCtD
Dopamine—Vomiting—Doxorubicin—pancreatic cancer	0.0002	0.00253	CcSEcCtD
Dopamine—Headache—Doxorubicin—pancreatic cancer	0.000197	0.0025	CcSEcCtD
Dopamine—Nausea—Doxorubicin—pancreatic cancer	0.000187	0.00237	CcSEcCtD
Dopamine—SLC6A4—digestive system—pancreatic cancer	0.000179	0.0307	CbGeAlD
Dopamine—MAOB—digestive system—pancreatic cancer	0.00017	0.0292	CbGeAlD
Dopamine—MAOA—pancreas—pancreatic cancer	0.00017	0.0291	CbGeAlD
Dopamine—HTR7—digestive system—pancreatic cancer	0.000152	0.026	CbGeAlD
Dopamine—CYP2C19—digestive system—pancreatic cancer	0.000148	0.0254	CbGeAlD
Dopamine—MAOA—digestive system—pancreatic cancer	0.000145	0.0249	CbGeAlD
Dopamine—SLC22A5—digestive system—pancreatic cancer	0.000134	0.0229	CbGeAlD
Dopamine—CYP1A2—digestive system—pancreatic cancer	0.000121	0.0208	CbGeAlD
Dopamine—CYP2C9—digestive system—pancreatic cancer	0.000115	0.0197	CbGeAlD
Dopamine—CYP2D6—digestive system—pancreatic cancer	8.62e-05	0.0148	CbGeAlD
Dopamine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.68e-05	6.12e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—pancreatic cancer	1.67e-05	6.08e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—STK11—pancreatic cancer	1.67e-05	6.07e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—pancreatic cancer	1.66e-05	6.06e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—pancreatic cancer	1.66e-05	6.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.65e-05	6.02e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	1.65e-05	6.01e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL8—pancreatic cancer	1.65e-05	6e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—pancreatic cancer	1.65e-05	6e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HRAS—pancreatic cancer	1.64e-05	5.97e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—pancreatic cancer	1.63e-05	5.95e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTEN—pancreatic cancer	1.61e-05	5.88e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCND1—pancreatic cancer	1.6e-05	5.84e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.59e-05	5.8e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	1.59e-05	5.8e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—pancreatic cancer	1.59e-05	5.8e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CTNNB1—pancreatic cancer	1.59e-05	5.79e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CD44—pancreatic cancer	1.58e-05	5.75e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	1.58e-05	5.75e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	1.58e-05	5.75e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—pancreatic cancer	1.58e-05	5.75e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.58e-05	5.75e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.57e-05	5.73e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.57e-05	5.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.57e-05	5.72e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	1.56e-05	5.7e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.56e-05	5.7e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—pancreatic cancer	1.56e-05	5.7e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	1.56e-05	5.68e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—pancreatic cancer	1.56e-05	5.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.55e-05	5.67e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PTEN—pancreatic cancer	1.55e-05	5.64e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.55e-05	5.64e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.54e-05	5.62e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KRAS—pancreatic cancer	1.54e-05	5.62e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCND1—pancreatic cancer	1.53e-05	5.59e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	1.53e-05	5.59e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.53e-05	5.58e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CB—pancreatic cancer	1.52e-05	5.55e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.52e-05	5.55e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.52e-05	5.54e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.52e-05	5.54e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CTNNB1—pancreatic cancer	1.52e-05	5.54e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GCG—pancreatic cancer	1.51e-05	5.52e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—pancreatic cancer	1.51e-05	5.5e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.51e-05	5.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.5e-05	5.48e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	1.49e-05	5.43e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—pancreatic cancer	1.49e-05	5.43e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.48e-05	5.41e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—pancreatic cancer	1.48e-05	5.4e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PTEN—pancreatic cancer	1.48e-05	5.4e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.47e-05	5.37e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	1.47e-05	5.36e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—pancreatic cancer	1.46e-05	5.33e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	1.46e-05	5.31e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—pancreatic cancer	1.45e-05	5.3e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.45e-05	5.27e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—pancreatic cancer	1.45e-05	5.27e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SRC—pancreatic cancer	1.43e-05	5.23e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.43e-05	5.22e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.43e-05	5.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.43e-05	5.22e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—STK11—pancreatic cancer	1.42e-05	5.19e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—pancreatic cancer	1.42e-05	5.17e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—pancreatic cancer	1.42e-05	5.16e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—pancreatic cancer	1.41e-05	5.15e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—pancreatic cancer	1.4e-05	5.1e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—pancreatic cancer	1.4e-05	5.09e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	1.39e-05	5.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.39e-05	5.05e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—pancreatic cancer	1.38e-05	5.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—pancreatic cancer	1.38e-05	5.04e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRAS—pancreatic cancer	1.38e-05	5.03e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SRC—pancreatic cancer	1.37e-05	5.01e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—pancreatic cancer	1.37e-05	4.99e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.37e-05	4.99e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.37e-05	4.99e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTEN—pancreatic cancer	1.36e-05	4.97e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—pancreatic cancer	1.36e-05	4.97e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—pancreatic cancer	1.35e-05	4.92e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—pancreatic cancer	1.34e-05	4.89e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—pancreatic cancer	1.34e-05	4.88e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.34e-05	4.87e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.34e-05	4.87e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTEN—pancreatic cancer	1.33e-05	4.86e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	1.33e-05	4.86e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.33e-05	4.84e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—pancreatic cancer	1.32e-05	4.83e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	1.32e-05	4.83e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.32e-05	4.83e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—pancreatic cancer	1.32e-05	4.82e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRAS—pancreatic cancer	1.32e-05	4.82e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTEN—pancreatic cancer	1.32e-05	4.8e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—pancreatic cancer	1.31e-05	4.77e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.31e-05	4.77e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.3e-05	4.74e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	1.29e-05	4.69e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—pancreatic cancer	1.29e-05	4.69e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—pancreatic cancer	1.28e-05	4.68e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—pancreatic cancer	1.28e-05	4.68e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOE—pancreatic cancer	1.28e-05	4.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	1.28e-05	4.65e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	1.28e-05	4.65e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTEN—pancreatic cancer	1.27e-05	4.63e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	1.27e-05	4.62e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—pancreatic cancer	1.26e-05	4.58e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—pancreatic cancer	1.25e-05	4.57e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	1.24e-05	4.53e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SRC—pancreatic cancer	1.24e-05	4.51e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.23e-05	4.49e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—pancreatic cancer	1.23e-05	4.49e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	1.23e-05	4.48e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—pancreatic cancer	1.23e-05	4.48e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.22e-05	4.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	1.22e-05	4.45e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SRC—pancreatic cancer	1.22e-05	4.45e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.21e-05	4.41e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	1.21e-05	4.4e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.2e-05	4.39e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—pancreatic cancer	1.2e-05	4.39e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.2e-05	4.38e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	1.2e-05	4.37e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—pancreatic cancer	1.19e-05	4.35e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRAS—pancreatic cancer	1.19e-05	4.34e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	1.19e-05	4.33e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—pancreatic cancer	1.19e-05	4.33e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	1.19e-05	4.33e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—pancreatic cancer	1.18e-05	4.29e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.18e-05	4.29e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.18e-05	4.28e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRAS—pancreatic cancer	1.17e-05	4.28e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	1.17e-05	4.26e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOE—pancreatic cancer	1.17e-05	4.25e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.17e-05	4.25e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—pancreatic cancer	1.16e-05	4.22e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	1.15e-05	4.2e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.15e-05	4.2e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	1.15e-05	4.18e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—pancreatic cancer	1.14e-05	4.15e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—pancreatic cancer	1.14e-05	4.15e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.12e-05	4.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	1.12e-05	4.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.11e-05	4.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.11e-05	4.05e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SRC—pancreatic cancer	1.11e-05	4.05e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—pancreatic cancer	1.11e-05	4.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.11e-05	4.03e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.1e-05	4.02e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—pancreatic cancer	1.09e-05	3.99e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	1.09e-05	3.98e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	1.09e-05	3.98e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	1.08e-05	3.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	1.08e-05	3.95e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.08e-05	3.94e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	1.07e-05	3.91e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.07e-05	3.91e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	1.07e-05	3.9e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	1.07e-05	3.9e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	1.06e-05	3.88e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	3.87e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—pancreatic cancer	1.06e-05	3.85e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.05e-05	3.83e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—pancreatic cancer	1.04e-05	3.81e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.04e-05	3.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	1.04e-05	3.77e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.03e-05	3.76e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	1.03e-05	3.74e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	1.02e-05	3.73e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.02e-05	3.73e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	1.02e-05	3.73e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.01e-05	3.7e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.01e-05	3.7e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.01e-05	3.69e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—pancreatic cancer	1.01e-05	3.68e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	1.01e-05	3.68e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	1.01e-05	3.68e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.01e-05	3.67e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—pancreatic cancer	9.96e-06	3.63e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOE—pancreatic cancer	9.96e-06	3.63e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	9.94e-06	3.62e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	9.82e-06	3.58e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	9.74e-06	3.55e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	9.67e-06	3.52e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	9.62e-06	3.51e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	9.53e-06	3.47e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	9.51e-06	3.46e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.42e-06	3.44e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	9.41e-06	3.43e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SRC—pancreatic cancer	9.34e-06	3.4e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	9.32e-06	3.4e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	9.32e-06	3.4e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—pancreatic cancer	9.3e-06	3.39e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	9.28e-06	3.38e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	9.24e-06	3.37e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	9.2e-06	3.36e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—pancreatic cancer	9.1e-06	3.32e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	9.09e-06	3.31e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	9e-06	3.28e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	8.99e-06	3.28e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	8.98e-06	3.27e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—pancreatic cancer	8.98e-06	3.27e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	8.97e-06	3.27e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	8.92e-06	3.25e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	8.84e-06	3.22e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	8.8e-06	3.21e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	8.76e-06	3.19e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	8.7e-06	3.17e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—pancreatic cancer	8.67e-06	3.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	8.59e-06	3.13e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	8.54e-06	3.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	8.46e-06	3.08e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—pancreatic cancer	8.37e-06	3.05e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	8.35e-06	3.04e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	8.18e-06	2.98e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—pancreatic cancer	8.18e-06	2.98e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	8.13e-06	2.96e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	8.09e-06	2.95e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	8.06e-06	2.94e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	8.05e-06	2.94e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	7.98e-06	2.91e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	7.9e-06	2.88e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—pancreatic cancer	7.86e-06	2.87e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	7.83e-06	2.85e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	7.82e-06	2.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	7.73e-06	2.82e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	7.68e-06	2.8e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTEN—pancreatic cancer	7.64e-06	2.78e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	7.58e-06	2.76e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	7.48e-06	2.73e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—pancreatic cancer	7.33e-06	2.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	7.1e-06	2.59e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.02e-06	2.56e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTEN—pancreatic cancer	6.96e-06	2.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	6.91e-06	2.52e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	6.89e-06	2.51e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—pancreatic cancer	6.87e-06	2.5e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	6.82e-06	2.49e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	6.61e-06	2.41e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	6.57e-06	2.4e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTEN—pancreatic cancer	5.95e-06	2.17e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	5.8e-06	2.11e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	5.39e-06	1.96e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.95e-06	1.81e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	4.91e-06	1.79e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—pancreatic cancer	4.4e-06	1.6e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	4.2e-06	1.53e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.05e-06	1.48e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—pancreatic cancer	4.01e-06	1.46e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—pancreatic cancer	3.43e-06	1.25e-05	CbGpPWpGaD
